Search results

New research has found no association between long-term cannabis use and cognitive decline in later life. Longitudinal data published in the journal Brain and Behavior, found no significant harmful effects of cannabis use on age-related cognitive decline. Researchers in Denmark examined the...

Via Business of Cannabis Mere hours after the results of the US election became clear, sending North American cannabis stocks into free fall, Germany’s ruling traffic light coalition all but collapsed, throwing the future of Europe’s largest and most promising cannabis market into uncertain...

Lifetime cannabis use is associated with several changes in brain structure and function in later life, suggests an observational study, but these associations may not be causal. This is according to researchers who conducted a genetic analysis of data from over 15,000 cannabis consumers in the...

A new study is the first to provide objective evidence that cannabinol (CBN) can improve sleep without any intoxicating effects. Research by scientists at the University of Sydney is the first to use objective measures to show the component, known as cannabinol (CBN), increases sleep in an...

Six years on from the legalisation of medical cannabis in the UK, families have made a fresh call for NHS access, as new figures reveal lack of prescribing. Families from across the UK returned to Westminster on Tuesday 5 November, clutching photos of their loved ones, along with stories and...

The Oireachtas Joint Committee on Drugs Use has published its interim report into the recommendations of Ireland’s landmark Citizens’ Assembly on Drugs Use, coming out strongly in favour of decriminalisation. Established earlier this year to further scrutinise the recommendations of the...

New findings have identified a significant decline in the percentage of US adolescents reporting current cannabis use over the last decade. The study, published in the journal Pediatric Reports, reveals that in 2011, 23.1% of adolescents indicated they were current users, but by 2021, this...

Events will take place at several major cities around the UK to raise awareness and bring medical cannabis education directly to the public. Patient advocates will visit Belfast, Birmingham, Glasgow, Cardiff and London throughout Medical Cannabis Awareness Week (1-7 November), to share their...

Approaching the sixth anniversary of the legalisation of medical cannabis in the UK, private prescriptions are on the rise, but broader awareness among professionals and the public still lags behind. After almost six years of medical cannabis being available on prescription in the UK, the...

Prescribing medical cannabis for chronic pain could save the NHS almost £4 billion annually, according to new research. The findings come from an independent economic analysis of medical cannabis for the treatment of chronic pain, undertaken by York Health-Economics Consortium at the University...

The majority of doctors in Germany can now prescribe medical cannabis for reimbursement without securing prior approval of the health insurance companies. It comes amid reports suggesting the German pharmacies are now key beneficiaries of the medical cannabis market, bringing in tens of...

UK medical cannabis experts have published a comprehensive review of evidence for the prescription of cannabis-based medicines in epilepsy. With over 280 references to peer-reviewed literature, Medical Cannabis & Epilepsy, published by Maple Tree Consultants, provides the first review of nearly...

Berlin, Germany – 16 October, 2024 – Following the adoption of the CanG and the associated MedCanG Act, the German medical cannabis market is witnessing significant growth, with German medical cannabis sales expected to reach €420 million in 2024, rising to over €1 billion by 2028. Published...

By Sarah Sinclair (Cannabis Health) with additional reporting from Ben Stevens Researchers say they are working to get two long-awaited NHS clinical trials underway to investigate the role of cannabis-based medicines in severe forms of epilepsy. The first significant update on the trials—first...

The number of items prescribed in the UK’s private medical cannabis market has doubled each year since 2021, as the market continues its rapid expansion. According to the latest figures from the NHS Business Services Authority (NHSBSA), published in response to an FOI request, the number of...

Ukraine’s Ministry of Health has approved the draft list of conditions for which medical cannabis can now be prescribed, excluding PTSD and other mental health disorders until more research is available. The impact of trauma and PTSD following Russia’s invasion of Ukraine played a key role in...

The THC-based drug dronabinol has been shown to reduce agitation in Alzheimer’s patients without adverse effects. Researchers have shown that a pill form of the drug dronabinol, an FDA-approved synthetic version of THC, reduces agitation in patients with Alzheimer’s by an average of 30%. The...

Spanish regulators have taken another step towards introducing the country’s long-delayed medical cannabis framework, but patients say the legislation does not go far enough. On Monday 30 September, the Ministry of Health published a draft royal decree for public hearing, setting out the...

Drug policy experts are calling for national education programs to tackle the lack of awareness and ‘stigmatising attitudes’ towards medical cannabis patients. In a new paper, researchers from Liverpool John Moores University, have highlighted how prohibitionist policies, and a lack of training...

A large percentage of people in their 50s and older have consumed at least one form of cannabis in the past year, a new US poll shows. According to new findings from the University of Michigan National Poll on Healthy Aging, 21% of people aged 50 and older said they used a form of cannabis that...